The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Volume Progression in Polycystic Kidney Disease
Open accessAbstract
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys. METHODS: In a three-year study, we measured the rates of change in total kidney volume, total cyst volume, and iothalamate clearance in patients with ADPKD. Of a total of 241 patients, in 232 patients without azotemia who were 15 to 46 years old at baseline we used magnetic-resonance imaging to correlate the total kidney volume and total cyst volume with iothalamate clearance. Statistical methods included analysis of variance, Pearson correlation, and multivariate regression analysis. RESULTS: Total kidney volume and total cyst volume increased exponentially, a result consistent with an expansion process dependent on growth. The mean (+/-SD) total kidney volume was 1060+/-642 ml at baseline and increased by a mean of 204+/-246 ml (5.27+/-3.92 percent per year, P<0.001) over a three-year period among 214 patients. Total cyst volume increased by 218+/-263 ml (P<0.001) during the same period among 210 patients. The baseline total kidney volume predicted the subsequent rate of increase in volume, independently of age. A baseline total kidney volume above 1500 ml in 51 patients was associated with a declining glomerular filtration rate (by 4.33+/-8.07 ml per minute per year, P<0.001). Total kidney volume increased more in 135 patients with PKD1 mutations (by 245+/-268 ml) than in 28 patients with PKD2 mutations (by 136+/-100 ml, P=0.03). CONCLUSIONS: Kidney enlargement resulting from the expansion of cysts in patients with ADPKD is continuous and quantifiable and is associated with the decline of renal function. Higher rates of kidney enlargement are associated with a more rapid decrease in renal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autosomal Dominant Polycystic Kidney Disease
Gabow, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290508 · Cited by 974
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Gabow, P. A., Johnson, A. M., Kaehny, W. D., Kimberling, W. J., Lezotte, D. C., Duley, I. T., & Jones, R. H. (1992) · Kidney International · doi:10.1038/ki.1992.195 · Cited by 509
Chapman, A. B., Guay-Woodford, L. M., Grantham, J. J., Torres, V. E., Bae, K. T., Baumgarten, D. A., Kenney, P. J., King, B. F., Glockner, J. F., Wetzel, L. H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00185.x · Cited by 413
Self-citationRapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease
Tao, Y., Kim, J., Schrier, R. W., & Edelstein, C. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080660 · Cited by 391
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
Torres, V. E., & Harris, P. C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0070 · Cited by 296
Self-citationGrantham, J. J., Chapman, A. B., & Torres, V. E. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00330705 · Cited by 278
Self-citationRuggenenti, P., Remuzzi, A., Ondei, P., Fasolini, G., Antiga, L., Ene-Iordache, B., Remuzzi, G., & Epstein, F. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00395.x · Cited by 270
Johnson, A. M., & Gabow, P. A. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8101560 · Cited by 202
Fick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M., & Schrier, R. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33379 · Cited by 178
A complete mutation screen of the ADPKD genes by DHPLC
Rossetti, S., Chauveau, D., Walker, D., Saggar-Malik, A., Winearls, C. G., Torres, V. E., & Harris, P. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00326.x · Cited by 170
Self-citationPain management in polycystic kidney disease
Bajwa, Z. H., Gupta, S. K., Warfield, C. A., & Steinman, T. I. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00985.x · Cited by 169
An Ultrasound Renal Cyst Prevalence Survey: Specificity Data for Inherited Renal Cystic Diseases
Ravine, D., Gibson, R. N., Donlan, J., & Sheffield, L. J. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70338-4 · Cited by 169
Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P. A., Dicks, E. L., Parfrey, P. S., Torrá, R., San‐Millán, J. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061774.90975.25 · Cited by 157
Pain patterns in patients with polycystic kidney disease
Bajwa, Z. H., Sial, K. A., Malik, A. B., & Steinman, T. I. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00921.x · Cited by 143
GFR determined by nonradiolabeled iothalamate using capillary electrophoresis
Wilson, D. M., Bergert, J. H., Larson, T. S., & Liedtke, R. R. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90488-1 · Cited by 133
King, B. F., Reed, J. E., Bergstralh, E. J., Sheedy, P. F., & Torres, V. E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181505 · Cited by 125
Self-citationO'Neill, W. C., Robbin, M. L., Bae, K. T., Grantham, J. J., Chapman, A. B., Guay‐Woodford, L. M., Torres, V. E., King, B. F., Wetzel, L. H., Thompson, P. A., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.026 · Cited by 113
Self-citationKing, B. F., Torres, V. E., Brummer, M. E., Chapman, A. B., Bae, K. T., Glockner, J. F., Arya, K., Felmlee, J. P., Grantham, J. J., Guay‐Woodford, L. M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00326.x · Cited by 108
Self-citationMechanisms of progression in autosomal dominant polycystic kidney disease.
Grantham, J. J. (1997) · PubMed · Cited by 92
Self-citationFactors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun, G. J., Itakura, Y., Albouze, G., Christophe, J. L., Man, N. K., Grünfeld, J., & Jungers, P. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v661634 · Cited by 88
Sise, C. B., Kusaka, M., Wetzel, L. H., Winklhofer, F. T., Cowley, B. D., Cook, L. T., Gordon, M. A., & Grantham, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00433.x · Cited by 78
Self-citationvan den Dool, S. W., Wasser, M. N. J. M., de Fijter, J. W., Hoekstra, J., & van der Geest, R. J. (2005) · Radiology · doi:10.1148/radiol.2361021463 · Cited by 61
Cystic Disease in Women: Clinical Characteristics and Medical Management
Chapman, A. B. (2003) · Advances in Renal Replacement Therapy · doi:10.1053/jarr.2003.50005 · Cited by 46
Self-citation
Cited by
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J., & Czerwiec, F. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205511 · Cited by 1,614
Self-citationAutosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationBergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Self-citationIrazabal, M. V., Rangel, L. J., Bergstralh, E. J., Osborn, S. L., Harmon, A. J., Sundsbak, J. L., Bae, K. T., Chapman, A. B., Grantham, J. J., Mrug, M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101138 · Cited by 625
Self-citation
Metadata
- Authors
- Grantham, J. J., Torres, V. E., Chapman, A. B., Guay-Woodford, L. M., Bae, K. T., King, B. F., Wetzel, L. H., Baumgarten, D. A., Kenney, P. J., Harris, P. C., Klahr, S., Bennett, W. M., Hirschman, G. N., Meyers, C. M., Zhang, X., Zhu, F., & Miller, J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-05-18
- Volume
- 354
- Issue
- 20
- Pages
- 2122-2130
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2055919784
- Cited by
- 807
- References
- 24
- FWCI
- 17.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.